Professional Documents
Culture Documents
net/publication/13336914
CITATIONS READS
303 2,002
1 author:
Leonard Hayflick
University of California, San Francisco
280 PUBLICATIONS 27,296 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Leonard Hayflick on 02 April 2019.
Occasional Paper
INTERNATIONAL
LONGEVITY CENTER–USA
Leonard Hayflick, Ph.D.
Harry R. Moody, Ph.D.
60 East 86th Street
New York, NY 10028
An Affiliate of
Mount Sinai School
of Medicine
The International Longevity Center–USA (ILC–USA)
is a not-for-profit, nonpartisan research, education, and
policy organization whose mission is to help individuals and
societies address longevity and population aging in positive
and productive ways and to highlight older people’s productivity
and contributions to their families and society as a whole.
Presented at the
55th Annual Scientific Meeting of
the Gerontological Society of America,
November 25, 2002
Preface
“DID ANYBODY EVER DIE OF OLD AGE?” increases our susceptibility to disease,” etc.4,5 But
refusing to call aging a “disease” is a presupposition
Logically, there are two answers to this question:
we could change.6,7 The fact that aging is
Yes and no. Both could imply the “end of aging
familiar and “normal” (as in “normal aging”) doesn’t
as we know it,” and the question itself has
mean we can’t declare it to be a disease and
assumed controversial status.1,2 Thus, if we answer
change our linguistic habits. We could begin to
the question with:
change our ordinary language this way, just as we
(1) Yes, people do die of old age, it means aging do when we speak of insomnia as a disease or
is a disease, so let’s find a cure for it. (And people alcoholism as a disease. 5
will live indefinitely.)
To think of aging as a disease becomes the strategy
(2) No, it means people die of some other disease, for “anti-aging medicine,” which may not now be
so let’s find a cure for those diseases. (And people a legitimate clinical field but could become an
will live indefinitely.) agenda for legitimate research in biogerontology.8
Indeed, some advocates of “transhumanism” in
Hmmm. Peculiar answers to what may be a
ethics argue strongly that life extension and even
peculiar question. Let’s examine these answers—
immortality should become our explicit research
yes and no—in terms of the logic of their
agenda. To call aging a disease isn’t a description
presuppositions and their implications for research
of current language so much as it is a decision
about aging. We will find that approaching the
about how we’re going to use language. Ordinary
question, “Did anybody ever die of old age?”
language, like scientific language, can change over
raises, in turn, profound questions about geronto-
time. But the decision here has a big consequence,
logical research, about fate and accident, and
and the consequence is that we begin to think
even about the human condition itself, questions
of aging as a condition that can be changed, even
with a long and venerable history.3
altered or abolished, just as one might imagine a
cure for progeria (a disease that causes accelerated
AGING IS A DISEASE
aging in childhood).
First let’s examine “Yes, … aging is a disease.”
Admittedly, it is peculiar to speak of aging itself CURE DISEASES ONE BY ONE
as a “disease.” Mainstream gerontology has spent
This first conclusion—aging is a disease—will be
a generation or two drumming into everyone’s
unpalatable to many, especially those who accept
head the dogma that “aging isn’t a disease, but it
Think of the aging body in comparison to an To understand the causal logic involved, compare
aging car or aging aircraft and consider the our question to another question: “Did anybody
engineering concept of “mean time to failure.” ever die of AIDS?” Now, we could reasonably
Just as aging aircraft are more vulnerable, so are answer, “No, nobody ever died of AIDS because
aging bodies. But, again, mean time to failure AIDS is simply a progressive collapse of immune
doesn’t cause anything; it’s just another statistical function.” Thus, people don’t die of “impaired
statement about probable longevity, in aircraft immune function,” they die from an opportunistic
or organic systems. infection or from a cancer or other organ failure,
but not from AIDS itself.
The difference is that biological systems, unlike
other natural objects such as a car or an aircraft, This would be a logical answer, but it’s an
have within them a capacity for repair and implausible one: a bit like saying, “Guns don’t kill
regeneration. Along these lines, Plato gave the people, people kill people.” The statement may
7
example of an old coat, constantly repaired, its be literally true, but it’s not very helpful because
material components always changing but its the proximate cause (a firearm) only becomes
identity of form remaining the same. So, too, effective when someone actually shoots the gun.
repair mechanisms at the cellular and molecular In the same way, rare forms of pneumonia kill
level give formal continuity, “sameness,” to the patients who have been compromised by AIDS.
human body. We wouldn’t want to say, “Nobody ever died of
AIDS” and therefore devote all our research
If we define aging as “impaired function with
efforts to finding cures for specific opportunistic
increased probability of death,” then we need to
infections that end up on the death certificates
look at the case of animals that do not age, such
of some AIDS patients.
as the hydra or sea anemone, which regenerates
itself (through budding) and shows a constant Thus, as with AIDS, the answer to the question
(not increasing) probability of death from preda- “Did anybody ever die of old age?” is both yes and
tors, accidents, and the like. The hydra, then, is no, because old age only “kills” when conjoined
not immortal—that is, it is not invulnerable. But with some specific (proximate) cause.
it lives indefinitely, which is the desired outcome
Conceived in this way, the strategy for curing AIDS
for the life-extension strategy.
becomes comparable to the strategy for “curing”
So we have come some distance in understanding aging: namely, eliminate those factors that permit
the logic of the question “Did anybody ever die proximate causes to be fatal.
of old age?,” and we understand something of the
Here lies the strategy for regenerative medicine
conceptual alternatives entailed by the question.
that could permit organisms to regenerate
It is not formal or statistical description or
Board of Directors
Laurance S. Rockefeller, Honorary Chair
Robert N. Butler, M.D., ILC–USA
Mary Carswell
Christine K. Cassel, M.D.
Everette E. Dennis, Ph.D.
Susan W. Dryfoos
Lloyd Frank
Annie Glenn
Senator John Glenn
Lawrence K. Grossman
Raymond L. Handlan
Robert D. Hormats
Tasneem Ismailji, M.D.
Rose Kleiner (1925-2001)
Linda P. Lambert
Max Link, Ph.D., Chair
William C. Martin
Evelyn Stefansson Nef
Stanley B. Prusiner, M.D.
Albert L. Siu, M.D., M.S.P.H.
Joseph E. Smith
Jackson T. Stephens, Jr.
Catharine R. Stimpson, Ph.D.
James H. Stone
William D. Zabel, Esq.
Mel Zuckerman
John F. Zweig
Directors
Robert N. Butler, M.D., ILC–USA
Shigeo Morioka, ILC–Japan
Françoise Forette, M.D., ILC–France
Baroness Sally Greengross, ILC–United Kingdom
Rosy Pereyra Ariza, M.D., ILC–Dominican Republic